Tight control and Type 1 diabetes

The Eurodiab Prospective Complications Study looked at glycaemic control and the mortality risk in Type 1 diabetes patients. Glycaemic targets, such as the HbA1c target, and the overall benefit of intensive glucose control are currently under debate as intensive glycaemic control has been suggested to have negative effects on mortality risk in Type 2 diabetes patients. The report examines the association between glycated hemoglobin (HbA1c) and all-cause mortality in patients with Type 1 diabetes mellitus.The study was performed in 2,764 European patients with Type 1 diabetes aged 15–60 years enrolled in the Eurodiab Prospective Complications Study and was collated over a seven-year period.

It was found that all-cause mortality risk was increased at both low (5.6%) and high (11.8%) HbA1c compared to the reference (median HbA1c: 8.1%).

The report concluded that target HbA1c below a certain threshold may not be appropriate in Type 1 diabetics.

Read more here.


Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags